Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Carfilzomib Enhances Iodine-125-Induced Cell Death in ESCC
2026-06-09
The referenced study demonstrates that Carfilzomib (PR-171), an irreversible proteasome inhibitor, significantly enhances the efficacy of Iodine-125 seed radiation in esophageal squamous cell carcinoma (ESCC) by aggravating endoplasmic reticulum stress and promoting multiple cell death pathways. These mechanistic insights offer new avenues for radiosensitization and therapeutic strategy development in treatment-resistant ESCC.
-
Practical Guide: FITC-Concanavalin A (ConA) Conjugate in Car
2026-06-08
FITC-Concanavalin A (ConA) Conjugate enables selective, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, addressing key needs in immunofluorescence and flow cytometry workflows. It should be used exclusively for carbohydrate-binding applications within its defined stability period, and is not appropriate for non-glycan or non-fluorescent assays.
-
Liposomal Co-Delivery of Cisplatin and Procainamide Hydrochl
2026-06-08
This study demonstrates that encapsulating both cisplatin and procainamide hydrochloride in liposomal carriers potentiates antiproliferative effects in cancer cell models while reducing toxicity. The findings provide new mechanistic insights into dual-agent delivery systems, with implications for optimizing combination chemotherapy and minimizing systemic side effects.
-
NU7441 (KU-57788): Precision DNA-PK Inhibition in DNA Repair
2026-06-07
NU7441 (KU-57788) empowers oncology and DNA repair research with nanomolar selectivity and robust workflow compatibility, offering unparalleled sensitivity in combination assays. By leveraging APExBIO’s trusted supply and integrating advanced protocol guidance, researchers can dissect DNA damage response mechanisms with confidence.
-
5-Methyl-CTP: Advancing mRNA Drug Development with Enhanced
2026-06-06
Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, is transforming mRNA synthesis and drug development by providing unprecedented mRNA stability and translation efficiency. This article uniquely connects molecular performance to next-generation vaccine delivery strategies and practical assay design.
-
Resveratrol and SIRT1: Advanced Mechanisms in Neuroprotectio
2026-06-05
Explore how Resveratrol, a potent SIRT1 activator, orchestrates mitochondrial biogenesis and apoptosis inhibition in neurodegenerative models. This in-depth analysis transcends standard reviews by connecting molecular mechanisms to practical assay design and highlighting new translational opportunities.
-
Resiniferatoxin Enables Precision TRPV1 Silencing for Analge
2026-06-05
Szallasi’s review highlights resiniferatoxin (RTX) as an ultra-potent, selective TRPV1 agonist that achieves targeted, long-lasting analgesia by chemically inactivating TRPV1-positive sensory neurons. This evidence-driven synthesis clarifies RTX’s mechanism, translational progress, and clinical potential in neuropathic and osteoarthritis pain, guiding advanced research workflows.
-
Heart–Insula Circuit in PTSD: Insights from Isoproterenol Mo
2026-06-04
This study elucidates how sympathetic cardiac overactivation, induced by isoproterenol, drives insular cortex hyperactivity and PTSD-like behaviors in mice. By dissecting the heart-brain axis via vagal mediation and demonstrating reversibility with propranolol, the research advances mechanistic understanding of PTSD pathogenesis and highlights methodological models for neurocardiac studies.
-
L-Phenylephrine: New Insights for α1A Adrenergic Signaling M
2026-06-04
Explore how L-Phenylephrine, a selective adrenergic α1A receptor agonist, advances cardiovascular and neural research. Discover deeper assay guidance, sex-specific implications, and protocol optimization overlooked by standard reviews.
-
CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce
2026-06-03
The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit enables stable, covalent fluorescent labeling for long-term cell tracking in cell proliferation and lineage tracing studies. Researchers should use this kit for workflows requiring durable cell identification, but avoid it in reversible or short-term labeling applications.
-
Spatially Patterned Kidney Assembloids Advance Disease Model
2026-06-03
The reference study introduces human kidney progenitor assembloids (hKPA) that recapitulate spatial self-assembly and functional maturation, overcoming major limitations of previous organoid models. These assembloids enable high-fidelity in vivo modeling of kidney diseases, with important implications for regenerative medicine and translational nephrology.
-
Jasplakinolide: Advanced Actin Polymerization Inducer Workfl
2026-06-02
Jasplakinolide empowers researchers to manipulate actin dynamics with nanomolar precision, enabling robust cytoskeletal studies and antifungal analyses. Explore optimized protocols, troubleshooting strategies, and actionable insights for extracting maximum value from this potent actin polymerization inducer.
-
Cycloheximide: Precision Protein Biosynthesis Inhibitor Work
2026-06-02
Cycloheximide is an essential tool for dissecting protein turnover and apoptosis, empowering researchers with unprecedented temporal control over translation arrest. This article translates recent advances in virology and cell biology into actionable protocols, troubleshooting insights, and practical enhancements for translational and disease model assays.
-
PXR Activation by Pregnenolone-16α-carbonitrile Inhibits Pyr
2026-06-01
This study demonstrates that activation of the pregnane X receptor (PXR) by pregnenolone-16α-carbonitrile (PCN) confers significant hepatoprotection against cholestatic liver injury by inhibiting both canonical and non-canonical pyroptosis pathways. These findings highlight the mechanistic role of PXR in regulating hepatocyte death and inflammation, suggesting new therapeutic avenues for cholestatic diseases.
-
OXER1 as a Redox Sensor: Safeguarding Intestinal Barrier Int
2026-06-01
This study uncovers the role of the G-protein coupled receptor OXER1 as a tissue redox sensor essential for maintaining intestinal epithelial barrier integrity. By dissecting the oxoeicosanoid signaling pathway in zebrafish and human models, the research reveals how OXER1-mediated signaling fortifies mucosal linings against oxidative stress, providing key mechanistic insights for apoptosis and inflammation research.